PEPCID AC TABLET

Страна: Канада

Язык: английский

Источник: Health Canada

Активный ингредиент:

FAMOTIDINE

Доступна с:

MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC

код АТС:

A02BA03

ИНН (Международная Имя):

FAMOTIDINE

дозировка:

10MG

Фармацевтическая форма:

TABLET

состав:

FAMOTIDINE 10MG

Администрация маршрут:

ORAL

Штук в упаковке:

18/30/60

Тип рецепта:

OTC

Терапевтические области:

HISTAMINE H2-ANTAGONISTS

Обзор продуктов:

Active ingredient group (AIG) number: 0118722003; AHFS:

Статус Авторизация:

APPROVED

Дата Авторизация:

2011-12-02

Характеристики продукта

_PEPCID AC_
_®_
_Page 1 of 18_
PRODUCT MONOGRAPH
PEPCID AC
®
famotidine tablets
FILM COATED TABLETS 10 MG
Mfr.
Std.
HISTAMINE H
2
RECEPTOR ANTAGONIST
McNeil Consumer Healthcare,
division of Johnson & Johnson Inc.
88 McNabb Street
Markham, Ontario
L3R 5L2
Date of Preparation:
February 14, 1996
Date of Revision:
May 24, 2019
Submission Control No: 225990
_PEPCID AC_
_®_
_Page 2 of 18_
_PEPCID AC_
_®_
_Page 3 of 18_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
.........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
....................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................3
ADVERSE REACTIONS
....................................................................................................4
DRUG INTERACTIONS
....................................................................................................5
DOSAGE AND ADMINISTRATION
................................................................................5
OVERDOSAGE
...................................................................................................................6
ACTION AND CLINICAL PHARMACOLOGY
...............................................................6
STORAGE AND STABILITY
............................................................................................8
DOSAGE FORMS, COMPOSITION AND PACKAGING
................................................8
PART II: SCIENTIFIC
INFORMATION................................................................................12
PHARMACEUTICAL INFORMATION
..........................................................................12
CLINICAL TRIALS
.......................................................